Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Burns Blaxall
PMWC Award Ceremony
• Euan Ashley, Stanford
• Jeffrey R. Balser, Vanderbilt
• Howard J. Jacob, Abbvie
Precision Medicine at Scale: Lessons from Vanderbilt
• Jeffrey R. Balser, Vanderbilt
From First Patient to a Million Genomes
• Chair: Howard J. Jacob, Abbvie
• Jeffrey R. Balser, Vanderbilt
• Euan Ashley, Stanford
Keynote: AI and Data-Driven Individual Health- Optimizing Wellness, Preventing Disease and Empowering Precision Medicine
• Lee Hood, Phenome Health
Keys to Successful Implementation of a Precision Medicine Program
• Chair: Howard McLeod, GeneDx
• Kevan Simms, Ochsner Health
• David Glazer, Verily
• Mark Atalla, HHS
• Susanne Munksted, Diaceutics
Precision Cardiology at Scale: Implementing Genomics Beyond Oncology
• Chair: Damon Hostin, Illumina
• David E. Lanfear, Henry Ford Health
• onit Yarden, NIH/NHLBI
Precision Medicine at Scale: Lessons from a Statewide Genomic Initiative
• Chair: Premal Shah, MyOme
• Niall Lennon, Broad Clinical Labs
• Oliver Hampton, Southern Research
Integrating Multi-Modal Biology into Precision Care Pathways: A Systems Framework for Scalable Implementation
• K V Venkatesh, IIT Mumbai
From Multi-Omics to Clinical Action: Making It Work at UCSF
• Marina Sirota, UCSF
From $/Gb to Outcomes: Simplifying Genomics for Health Systems
• Jacob Thaysen, Illumina
Achieving Comprehensive Precision Medicine
• Chair: Burns Blaxall
• Trish Brown, GeneDx
• Eric Green, Illumin
• Daryl Pritchard, Personalized Medicine Coalition
• Ora Gordon, Providence Health
• Sarah Hersey, BMS
Speaker Profile
Biography
Innovative Senior Data Scientist with over 10 years of leadership experience in biomarker discovery, advanced analytics for drug development, clinical data science and AI implementation. Proven expertise in integrating multi-modal data, deploying AI-driven solutions across clinical research environments, and fostering strategic collaborations internally and externally to deliver high-impact results. Recognized for excellence in aligning scientific expertise with business needs to drive actionable insights and improve decision-making.
In her current role, she helps Novo Nordisk's longevity task force to understand the longevity potential of its assets, design longevity-focused clinical trials, and engage with regulatory authorities to define longevity outcomes. She also analyses omics data from RCTs to understand drug mode of action and identify responders to treatment.
Speaker Profile
Biography
Dr. Daniel Knecht, M.D., M.B.A., is the Chief Medical Officer and Senior Vice President of EmblemHealth, where he leads clinical strategy to improve health outcomes for approximately 3 million New Yorkers. Previously, he served as Chief Clinical Innovation Officer at CVS Caremark, focusing on enhancing patient outcomes and managing healthcare costs.
Before CVS, Dr. Knecht directed clinical strategy and medical policy initiatives at Aetna, where he implemented successful quality improvement projects, including addressing the opioid crisis and gene therapy reimbursement strategies.
Dr. Knecht is a Fulbright Scholar and an accomplished academic. He graduated cum laude from Dartmouth College with a degree in Biochemistry and Molecular Biology and earned his joint M.D.,M.B.A. from Weill Cornell Medical College and Johnson Graduate School of Management, where he was awarded the Lee Family Scholarship.
Dr. Knecht is also a practicing hospitalist at Mount Sinai West in New York City, where he serves as an Assistant Clinical Professor. In addition, he contributes his expertise to public health as a board member of the CUNY School of Public Health Foundation and as an advisor to Monogram Health, focusing on advancing care models for chronic kidney disease.
Dr. Knecht’s innovative contributions to healthcare have earned him widespread recognition, including being named one of Modern Healthcare’s 40 Under 40 in February 2024. His career reflects a deep commitment to bridging clinical care and healthcare innovation, positioning him as a transformative leader in the industry.
Speaker Profile
Biography
Michael A. Pfeffer, MD, FACP serves as Chief Information and Digital Officer and Associate Dean for Stanford Health Care and Stanford University School of Medicine. Michael oversees Technology and Digital Solutions (TDS), responsible for providing world class technology solutions to Stanford Health Care and School of Medicine, enabling new opportunities for groundbreaking research, teaching, and compassionate care across two hospitals and over 150 clinics. TDS supports Stanford Medicines mission to improve human health through discovery and care and strategic priorities to be value focused, digitally driven, and uniquely Stanford. Michael is a Clinical Professor in the Department of Medicine and Division of Hospital Medicine with a joint appointment in the center for Biomedical Research (BMIR) in Stanford University School of Medicine.
Speaker Profile
Biography
Peter Hulick, MD, a clinical geneticist and chair of personalized medicine at Endeavor Health, helps patients understand how genomic information can inform care and improve health outcomes. With a career rooted in genetics since high school, he works to integrate genomic data into everyday decision-making for patients and clinicians. Dr. Hulick focuses on risk assessment, early detection and treatment guidance by combining science, patient context and team collaboration. He also leads efforts to make genomic care more accessible across the health system.
Speaker Profile
Biography




